MedEquity Capital

Qler Solutions LLC, established in 2016 and located in Reston, Virginia, specializes in providing an on-demand solution for delivering psychiatric care across diverse healthcare settings in the United States. Their services cater to a variety of environments, including emergency departments, medical-surgical floors, behavioral inpatient units, clinics, and nursing homes. By focusing on enhancing access to psychiatric care, Qler Solutions aims to address the increasing demand for mental health services in a timely and efficient manner.

LeadScope, Inc. specializes in the development and marketing of a chemoinformatics application that provides access to critical research data. The company offers a range of services including toxicity databases, data management, decision support solutions, and tools for in silico toxicology, data mining, high-throughput screening analysis, lead optimization, and compound acquisition. LeadScope serves a diverse clientele that includes national laboratories, pharmaceutical and biotechnology firms, chemical manufacturers, consumer products companies, and regulatory agencies across the United States, Canada, and Europe. Founded in 1997 and headquartered in Columbus, Ohio, LeadScope operates as a subsidiary of Instem plc as of November 2019.

LiceGuard is a company focused on the treatment and prevention of lice through the development of non-toxic and pesticide-free products. Its offerings are designed to detect and eliminate lice effectively without the use of harmful chemicals, providing a natural solution for individuals dealing with lice infestations. By prioritizing safety and efficacy, LiceGuard aims to address lice problems in a way that is both effective and gentle on users.

Oncure was founded in 1998 and is dedicated to helping patients fight cancer through the delivery of extraordinary care. In addition, Oncure offers patients access to many of the most advanced technologies in radiation treatment. See Treatment Options for more information. Oncure does not own nor manage physician practices, rather it collaborates with its affiliated radiation oncologists to provide quality patient treatment. See Medical Advisory Board for details.

Decision Management International, Inc. (DMI) is a leading provider of software products and consulting services for companies in FDA-regulated industries. They are internationally recognized for the development of paperless solutions for cGMP manufacturing operations that greatly reduce operational complexities and costs. These efficiencies have proven advantageous for heavily regulated companies that require detailed documentation and compliance reporting to various governmental agencies. DMI's fully integrated software product suite addresses documentation compliance procedures in the pharmaceutical, biotechnology, medical device and similar industries. DMI was established in 1993 as a consulting firm for pharmaceutical and related industries. Since its founding, DMI has developed successful complexity reduction software that leverages the Company's domain expertise. The Company, a Microsoft Certified Partner, initially created a document authoring solution and subsequently developed a technically innovative product suite that integrates document authoring, archiving, and electronic batch record solutions software for clients throughout the U.S., Canada and Europe. The Company's solid consulting track record and superior software applications have resulted in ongoing and repeat business engagements with its existing clients. In addition, DMI continues to attract an impressive roster of new clients.

VelQuest Corporation is the global leader in lab execution and instrument data capture software for pharmaceutical and medical device manufacturers. VelQuest solutions for lab information management, lab execution, batch record execution, and electronic data capture replace manual paper-based documentation processes, helping manufacturers to improve efficiency and reduce GMP compliance risks in quality and manufacturing operations.

TransMedics is a medical technology company focused on improving organ transplant therapy for patients with end-stage organ failure. Headquartered in Andover, Massachusetts, it has developed the Organ Care System (OCS), a portable organ perfusion and monitoring device that mimics near-physiologic conditions for donor organs outside the human body. This system includes specialized devices for different organs, such as OCS LUNG, which maintains lungs in a viable state for assessment and optimization, OCS Heart, designed to preserve hearts in a metabolically active state, and OCS Liver, currently under clinical trials. By addressing the limitations of traditional cold storage methods, TransMedics aims to enhance organ preservation and increase the availability of organs for transplantation, thereby improving outcomes for patients in need. Founded in 1998, the company is at the forefront of innovation in organ transplant technology.